NEJM -- Table of Contents (March 27 1975, 292 [13])

	Previous	Volume 292		March 27, 1975		Number 13	Next

Use of an angiotensin II antagonist (saralasin) in the recognition of "angiotensinogenic" hypertension;
D. H. Streeten, G. H. Anderson, J. M. Freiberg, and T. G. Dalakos
Abstract

Ventilatory control in myxedema and hypothyroidism
C. W. Zwillich and Others
Abstract

Comparison of 125I fibrinogen count scanning with phlebography for detection of venous thrombi after elective hip surgery
W. H. Harris and Others
Abstract

PSRO: an educational force for improving quality of care
W. F. Jessee, W. B. Munier, J. E. Fielding, and M. J. Goran
Abstract

Relation between quality assessment and utilization review in a functioning PSRO
A. R. Nelson
Abstract

Hereditary defects affecting fertility
N. E. Reame and E. S. Hafez

Current concepts measurement of cardiac output by thermodilution
R. D. Weisel, R. L. Berger, and H. B. Hechtman

Fiber embolization--a hazard of cardiac surgery and catheterization,
J. E. Dimmick, K. E. Bove, A. J. McAdams, and G. Benzing

The public health--continuing discord--crash call
J. Lister

Medicine and public affairs. "Progress" in cancer research--don't say it isn't so
D. S. Greenberg

Weekly clinicopathological exercises. Case 13-1975

Angiotensin blockade: new pharmacologic tools for understanding and treating hypertension
J. H. Laragh

Detritemia
F. J. Ingelfinger

The Edelin trial fiasco
F. J. Ingelfinger

Defective cell maturation in combined immunotherapy
P. D. Bertram

Back-pack meralgia
A. R. MacKay

Smoking by airline pilots
W. Bigelow

The end-result system
G. A. Degenshein and F. Ceccarelli

Edelin supported

[Note: This page was generated from the Medline data base.
There may be some discrepancies between the page shown and the original printed version.]

Comments and questions? Please contact us.